BriaCell adds Penn Medicine cancer center to phase 3 breast cancer trial

May 13, 2026 7:30 AM

BriaCell Therapeutics Corp. (NASDAQ: BCTX, BCTXL) (TSX: BCT) announced the addition of Penn Medicine's Abramson Cancer Center as a clinical ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found